<DOC>
	<DOCNO>NCT00897741</DOCNO>
	<brief_summary>RATIONALE : Studying sample tumor tissue patient cancer laboratory may help doctor learn change may occur DNA identify biomarkers related cancer . PURPOSE : This laboratory study use gene expression profile compare primary tumor cell metastatic tumor cell patient metastatic pancreatic cancer .</brief_summary>
	<brief_title>Gene Expression Profiles Patients With Metastatic Pancreatic Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Compare gene expression profile pancreatic cancer cell primary metastatic site patient metastatic pancreatic cancer . - Characterize function differentially upregulated downregulated gene identify compare gene expression profile primary metastatic cell patient . OUTLINE : Fresh biopsy sample collect gene expression profile biomarker/laboratory analysis . PROJECTED ACCRUAL : A total 10 patient accrue study .</detailed_description>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis pancreatic adenocarcinoma exocrine origin Metastatic disease Fresh biopsy material available primary site disease metastatic focus , include liver , peritoneum , lymph node PATIENT CHARACTERISTICS : Not specify PRIOR CONCURRENT THERAPY : No prior chemotherapy radiotherapy pancreatic cancer</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>recurrent pancreatic cancer</keyword>
	<keyword>stage IV pancreatic cancer</keyword>
</DOC>